Japan accepts GSK Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk Ruchika Sharma14 Dec 2023 10:00 AM ISTLondon: GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a regulatory application to extend...
Prenatal infection with respiratory virus tied to inflammation and poorer growth in fetus Jacinthlyn Sylvia13 Dec 2023 4:00 PM ISTIn a recent study by researchers have shed light on the intricate dynamics of vertical transmission of respiratory viruses from pregnant women to...
Clofazimine effective alternative to rifampicin for treating Mycobacterium avium lung disease: Study Medha Baranwal13 Dec 2023 10:15 AM ISTNetherlands: Findings from a randomized trial showed clofazimine to be a safe and effective alternative to rifampicin for the treatment of...
Marijuana, cigarette smokers at increased risk of emphysema Roshni Dhar13 Dec 2023 9:00 AM ISTSmoking marijuana in combination with cigarettes may lead to increased damage of the lung's air sacs, according to research being presented today at...
Breakthrough Treatment for Allergic Rhinitis: Intratonsillar Injection Shows Promising Results in Clinical Trial Dr.Niharika Harsha B13 Dec 2023 3:00 AM ISTIn a groundbreaking clinical trial, researchers have discovered a novel approach to treating house dust mite (HDM)-induced allergic rhinitis (AR) that...
Potential new treatment for patients with pulmonary neuroendocrine tumors discovered Dr. Kamal Kant Kohli13 Dec 2023 1:30 AM ISTNetherlands: A recent study published in Cancer Cell has revealed a way to grow samples of different neuroendocrine tumour (NETs) types in the...
AstraZeneca to acquire vaccine developer Icosavax for up to USD 1.1 billion Ruchika Sharma12 Dec 2023 3:30 PM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc., a US-based clinical-stage biopharmaceutical company...
Major breakthrough-Benralizumab may independently control severe asthma without use of inhaled steroids Dr. Kamal Kant Kohli12 Dec 2023 9:45 AM ISTA landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids...
Even little physical activity could be valuable in late-stage lung cancer Roshni Dhar12 Dec 2023 9:30 AM ISTNew research has found less than five minutes of daily physical activity could be linked with prolonged life in people living with inoperable forms of...
Type of Allergy medicine may have role in treatment of lung cancer Dr. Kamal Kant Kohli11 Dec 2023 9:45 AM ISTUSA: A recent study published in Nature has identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of...
Adenotonsillectomy beneficial for children with mild sleep apnea: JAMA Dr. Kamal Kant Kohli11 Dec 2023 9:30 AM ISTUSA: Adenotonsillectomy, compared with watchful waiting fails to significantly improve executive function or attention at 12 months in children with...
Merck announces positive results from phase 2 trial evaluating coformulation of vibostolimab, pembrolizumab in lung cancer patients Ruchika Sharma10 Dec 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced full results from the non-registrational Phase 2 KeyVibe-002...
